Shares of Viatris, Inc. (VTRS) lost 4.8% in the last three trading sessions after the company reported lower-than-expected fourth-quarter results on Feb 28, before market open.Fourth-quarter 2023 adjusted earnings of 61 cents per share missed the Zacks Consensus Estimate of 67 cents.Total revenues came in at $3.8 billion, up 1% year over year on a divestiture-adjusted operational basis. However, the top line missed the Zacks Consensus Estimate of $3.9 million.Branded business grew 3%, driven by brands like ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2023 OR ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 001-39695 VIATRIS INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (I.R.S. ...

Greater China performed ahead of our expectations for the full-year 2023, delivering 2% growth, driven by strong performance of our retail channel in China. This is a result of our ability to adapt our business model to the evolving market dynamics. Moving to JANZ. Full-year '23 came in below our expectations due to the continued impacts from the government-driven price regulations in this region, which we expect to continue into 2024. We anticipate to partially offset the pricing dynamics with the ongoing ...

Viatris Inc. (VTRS) delivered adjusted earnings of 61 cents per share in the fourth quarter of 2023, missing the Zacks Consensus Estimate of 67 cents. The company recorded adjusted earnings of 67 cents in the year-ago quarter.Total revenues came in at $3.8 billion, up 1% year over year on a divestiture-adjusted operational basis. Revenues include product sales and other revenues. The top line missed the Zacks Consensus Estimate of $3.9 million.Viatris’ stock has declined in the premarket due to the disappoi ...

For the quarter ended December 2023, Viatris (VTRS) reported revenue of $3.84 billion, down 1% over the same period last year. EPS came in at $0.61, compared to $0.69 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $3.92 billion, representing a surprise of -2.22%. The company delivered an EPS surprise of -8.96%, with the consensus EPS estimate being $0.67.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they ...

PITTSBURGH, Feb. 28, 2024 /PRNewswire/ -- Meets 2023 Guidance for Total Revenues, Adjusted EBITDA and Free Cash Flow[1]   Reports 2023 Total Revenues of $15.4 Billion, U.S. GAAP Net Earnings of $54.7 Million, Adjusted EBITDA of $5.1 Billion, U.S. GAAP Net Cash Provided by Operating Activities of $2.8 Billion and Free Cash Flow of $2.4 Billion   Reports Third Consecutive Quarter of Operational Revenue Growth on a Divestiture-Adjusted Basis in 2023 and Expects to see Continued Growth in 2024[2]   Immediatel ...

Ad hoc announcement pursuant to Art. 53 LR Viatris and Idorsia will collaborate on the global development and commercialization of two Phase 3 assets, selatogrel and cenerimod.Idorsia to receive an upfront payment of USD 350 million, potential development and regulatory milestone payments, additional sales milestone payments and tiered royalties on annual net sales.Viatris and Idorsia will both contribute to the development costs for both programs.Includes future optionality to expand collaboration with add ...

Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance PITTSBURGH – Feb. 28, 2024 – Viatris Inc. (NASDAQ: VTRS) today announced its financial results for the fourth quarter and full year 2023. Financial Impact of Transactions and Acquired IPR&D | ($M) | 2023 Guidance Ranges | – | Divestitures and (1) Acquisitions | – | Acquired (2) IPR&D | = | 2023 Adjusted Guidance Ranges | 2023 Results | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Total Reven ...

Viatris (VTRS) , a global healthcare company, is scheduled to report fourth-quarter results on Feb 28, 2024. The company’s earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 6.02%. In the last reported quarter, the company delivered an average surprise of 5.41%. Factors to Consider Viatris reports segmental results based on markets and geography — Developed Markets, Emerging Markets, Japan, Australia and New Zealand (JANZ) and Greater China. The negative impact ...

Wall Street analysts forecast that Viatris (VTRS) will report quarterly earnings of $0.67 per share in its upcoming release, pointing to a year-over-year decline of 2.9%. It is anticipated that revenues will amount to $3.92 billion, exhibiting an increase of 1% compared to the year-ago quarter.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this time ...